Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 6/2019

06.03.2019 | Original Article

Intensive multidisciplinary management in critical care patients affected by severe necrotizing soft tissue infections: a cooperative method to improve the efficacy of treatment

verfasst von: Milo Gatti, Laura Elisa Gasparini, Matteo Laratta, Anna Sigurtà, Anna Rossi, Paolo Brioschi, Osvaldo Chiara, Chiara Vismara, Francesco Scaglione, Sergio Arlati

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

To illustrate the effectiveness of our intensive multidisciplinary management (IMM) in the treatment of severely ill patients with necrotizing soft tissue infections (NSTIs). A retrospective observational study was conducted in a general ICU. Thirty-two consecutive patients undergoing IMM were carefully compared with 30 consecutive patients receiving a standard management (SM). IMM combined intensive care management, early surgical debridement followed by daily inspection of surgical wounds, close microbiological surveillance, and targeted high-dose antibiotics. IMM was associated with the better decrease of daily SOFA score (p = 0.04). Also, IMM caused + 12% increase in the overall number of surgical procedures (p = 0.022) and a higher number of tissue biopsies/per day (median 0.63 versus 0.32; p = 0.025), leading to a more targeted antimicrobial changes (89.6% vs 51.6%; p < 0.00001). High-dose daptomycin (75% vs 36.7%; p = 0.002) and extended/continuous infusion of beta-lactams (75% vs 43.3%; p = 0.011) were more frequently utilized. A specific efficiency score correlated with the decrease of SOFA score (efficacy) in IMM patients only (p = 0.027). Finally, IMM was associated with a significant lower ICU mortality rate (15.6% vs 40%; p = 0.032). IMM was more effective than SM as it allowed the earlier control of infection and the faster reduction of multiple organ-dysfunction.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ellis Simonsen SM, van Orman ER, Hatch BE, Jones SS, Gren LH, Hegmann KT, Lyon JL (2006) Cellulitis incidence in a defined population. Epidemiol Infect 134(2):293–299CrossRefPubMed Ellis Simonsen SM, van Orman ER, Hatch BE, Jones SS, Gren LH, Hegmann KT, Lyon JL (2006) Cellulitis incidence in a defined population. Epidemiol Infect 134(2):293–299CrossRefPubMed
2.
Zurück zum Zitat Anaya DA, Dellinger EP (2007) Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis 44(5):705–710CrossRefPubMed Anaya DA, Dellinger EP (2007) Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis 44(5):705–710CrossRefPubMed
3.
Zurück zum Zitat McHenry CR, Piotrowski JJ, Petrinic D, Malangoni MA (1995) Determinants of mortality for necrotizing soft-tissue infections. Ann Surg 221(5):558–565CrossRefPubMedPubMedCentral McHenry CR, Piotrowski JJ, Petrinic D, Malangoni MA (1995) Determinants of mortality for necrotizing soft-tissue infections. Ann Surg 221(5):558–565CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Anaya DA, McMahon K, Nathens A, Sullivan SR, Foy H, Bulger E (2005) Predictors of mortality and limb loss in necrotizing soft tissue infections. Arch Surg 140:151–158CrossRefPubMed Anaya DA, McMahon K, Nathens A, Sullivan SR, Foy H, Bulger E (2005) Predictors of mortality and limb loss in necrotizing soft tissue infections. Arch Surg 140:151–158CrossRefPubMed
5.
Zurück zum Zitat Boyer A, Vargas F, Coste F, Saubusse E, Castaing Y, Gbikpi-Benissan G, Hilbert G, Gruson D (2009) Influence of surgical treatment timing on mortality from necrotizing soft tissue infections requiring intensive care management. Intensive Care Med 35(5):847–853CrossRefPubMed Boyer A, Vargas F, Coste F, Saubusse E, Castaing Y, Gbikpi-Benissan G, Hilbert G, Gruson D (2009) Influence of surgical treatment timing on mortality from necrotizing soft tissue infections requiring intensive care management. Intensive Care Med 35(5):847–853CrossRefPubMed
6.
Zurück zum Zitat Voros D, Pissitois C, Georgantas D, Katsaragakis S, Antoniou S, Papadimitriou J (1993) Role of early and extensive surgery in the treatment of severe necrotizing soft tissue infection. Br J Surg 80(9):1190–1191CrossRefPubMed Voros D, Pissitois C, Georgantas D, Katsaragakis S, Antoniou S, Papadimitriou J (1993) Role of early and extensive surgery in the treatment of severe necrotizing soft tissue infection. Br J Surg 80(9):1190–1191CrossRefPubMed
7.
Zurück zum Zitat Bilton BD, Zibari GB, McMillan RW, Aultman DF, Dunn G, McDonald JC (1998) Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study. Am Surg 64(5):397–400PubMed Bilton BD, Zibari GB, McMillan RW, Aultman DF, Dunn G, McDonald JC (1998) Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study. Am Surg 64(5):397–400PubMed
8.
Zurück zum Zitat Hadeed GJ, Smith J, O’Keeffe, Kulvatunyou N, Wynne JL, Joseph B, Friese RS, Wachtel TL, Rhee PM, El-Menyar A et al (2016) Early surgical intervention and its impact on patients presenting with necrotizing soft tissue infections: a single academic center experience. J Emerg Trauma Shock 9(1):22–27CrossRefPubMedPubMedCentral Hadeed GJ, Smith J, O’Keeffe, Kulvatunyou N, Wynne JL, Joseph B, Friese RS, Wachtel TL, Rhee PM, El-Menyar A et al (2016) Early surgical intervention and its impact on patients presenting with necrotizing soft tissue infections: a single academic center experience. J Emerg Trauma Shock 9(1):22–27CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Wong CH, Haw-Chong C, Shanker P, Khin LW, Tan JL, Low CO (2003) Necrotizing fasciitis: clinical presentation, microbiology and determinants of mortality. J Bone Joint Surg Am 85(8):1454–1460CrossRefPubMed Wong CH, Haw-Chong C, Shanker P, Khin LW, Tan JL, Low CO (2003) Necrotizing fasciitis: clinical presentation, microbiology and determinants of mortality. J Bone Joint Surg Am 85(8):1454–1460CrossRefPubMed
10.
Zurück zum Zitat Elliot DC, Kufera JA, Myers RAM, Necrotizing soft tissue infections (1996) Risk factors for mortality and strategies for management. Ann Surg 224(5):672–683CrossRef Elliot DC, Kufera JA, Myers RAM, Necrotizing soft tissue infections (1996) Risk factors for mortality and strategies for management. Ann Surg 224(5):672–683CrossRef
11.
Zurück zum Zitat Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC (2014) Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis 59(2):e10–e52CrossRef Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC (2014) Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis 59(2):e10–e52CrossRef
12.
Zurück zum Zitat Okoye O, Talving P, Lam L, Smith J, Teixeira PG, Inaba K, Koronakis N, Demetriades D (2013) Timing of redébridement after initial source control impacts survival in necrotizing soft tissue infection. Am Surg 79(10):1081–1085PubMed Okoye O, Talving P, Lam L, Smith J, Teixeira PG, Inaba K, Koronakis N, Demetriades D (2013) Timing of redébridement after initial source control impacts survival in necrotizing soft tissue infection. Am Surg 79(10):1081–1085PubMed
13.
Zurück zum Zitat Stevens DL, Bryant AE (2017) Necrotizing soft-tissue infections. N Engl J Med 377(23):2253–2265CrossRefPubMed Stevens DL, Bryant AE (2017) Necrotizing soft-tissue infections. N Engl J Med 377(23):2253–2265CrossRefPubMed
14.
Zurück zum Zitat de Prost N, Sbidian E, Chosidow O, Brun-Buisson C, Amathieu R (2015) Management of necrotizing soft tissue infections in the intensive care unit: results of an international survey. Intensive Care Med 41(8):1506–1508CrossRefPubMed de Prost N, Sbidian E, Chosidow O, Brun-Buisson C, Amathieu R (2015) Management of necrotizing soft tissue infections in the intensive care unit: results of an international survey. Intensive Care Med 41(8):1506–1508CrossRefPubMed
15.
Zurück zum Zitat Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 26(11):1793–1800CrossRefPubMed Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 26(11):1793–1800CrossRefPubMed
16.
Zurück zum Zitat Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/north American multicenter study. JAMA 270(24):2957–2963CrossRef Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/north American multicenter study. JAMA 270(24):2957–2963CrossRef
17.
Zurück zum Zitat Wong CH, Khin LW, Heng KS, Tan KC, Low CO (2004) The LRINEC (Labroatory risk indicator for necrotizing fasciitis) score: a tool for distinguishing necrotizing fasciitis form other soft tissue infections. Crit Care Med 32(7):1535–1541CrossRefPubMed Wong CH, Khin LW, Heng KS, Tan KC, Low CO (2004) The LRINEC (Labroatory risk indicator for necrotizing fasciitis) score: a tool for distinguishing necrotizing fasciitis form other soft tissue infections. Crit Care Med 32(7):1535–1541CrossRefPubMed
19.
Zurück zum Zitat Roberts JA, Lipman J (2009) Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 37(3):840–851CrossRef Roberts JA, Lipman J (2009) Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 37(3):840–851CrossRef
20.
Zurück zum Zitat Abdul-Aziz MH, Lipman J, Roberts JA (2017) Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections. Crit Care 21(1):283–285CrossRefPubMedPubMedCentral Abdul-Aziz MH, Lipman J, Roberts JA (2017) Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections. Crit Care 21(1):283–285CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Ulldemolins M, Roberts JA, Lipman J, Rello J (2011) Antibiotic dosing in multiple organ dysfunction syndrome. Chest 139(5):1210–1220CrossRefPubMed Ulldemolins M, Roberts JA, Lipman J, Rello J (2011) Antibiotic dosing in multiple organ dysfunction syndrome. Chest 139(5):1210–1220CrossRefPubMed
22.
Zurück zum Zitat Blot S, Lipman J, Roberts DM, Roberts JA (2014) The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary? Diagn Microbiol Infect Dis 79(1):77–84CrossRefPubMed Blot S, Lipman J, Roberts DM, Roberts JA (2014) The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary? Diagn Microbiol Infect Dis 79(1):77–84CrossRefPubMed
23.
Zurück zum Zitat De Prost N, Lipman J, Mimoz O (2017) Therapeutic targets in necrotizing soft tissue infections. Intensive Care Med 43(11):1717–1719CrossRefPubMed De Prost N, Lipman J, Mimoz O (2017) Therapeutic targets in necrotizing soft tissue infections. Intensive Care Med 43(11):1717–1719CrossRefPubMed
24.
Zurück zum Zitat D’Avolio A, Pensi D, Baietto L, Pacini G, Di Perri G, De Rosa FG (2016) Daptomycin pharmacokinetics and pharmacodynamics in septic and critically ill patients. Drugs 76(12):1161–1174CrossRefPubMed D’Avolio A, Pensi D, Baietto L, Pacini G, Di Perri G, De Rosa FG (2016) Daptomycin pharmacokinetics and pharmacodynamics in septic and critically ill patients. Drugs 76(12):1161–1174CrossRefPubMed
25.
Zurück zum Zitat Kiang TKL, Häfeli UO, Ensom MHH (2014) A comprehensive review on the pharmacokinetics of antibiotics in interstitial fluid spaces in humans: implications on dosing and clinical pharmacokinetic monitoring. Clin Pharmacokinet 53(8):695–730CrossRefPubMed Kiang TKL, Häfeli UO, Ensom MHH (2014) A comprehensive review on the pharmacokinetics of antibiotics in interstitial fluid spaces in humans: implications on dosing and clinical pharmacokinetic monitoring. Clin Pharmacokinet 53(8):695–730CrossRefPubMed
26.
Zurück zum Zitat Hancock RE (2005) Mechanisms of action of newer antibiotics for Gram-positive pathogens. Lancet Infect Dis 5(4):209–218CrossRefPubMed Hancock RE (2005) Mechanisms of action of newer antibiotics for Gram-positive pathogens. Lancet Infect Dis 5(4):209–218CrossRefPubMed
27.
Zurück zum Zitat Roberts J, Gavin MJ, Gordon Y, Choi S, Gomersall CD, Lipman J (2012) How to optimise antimicrobial prescriptions in the intensive care unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics. Int J Antimicrob Agents 39(3):187–192CrossRefPubMed Roberts J, Gavin MJ, Gordon Y, Choi S, Gomersall CD, Lipman J (2012) How to optimise antimicrobial prescriptions in the intensive care unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics. Int J Antimicrob Agents 39(3):187–192CrossRefPubMed
28.
Zurück zum Zitat Blot SI, Pea F, Lipman J (2014) The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents. Adv Drug Deliv Rev 77:3–11CrossRefPubMed Blot SI, Pea F, Lipman J (2014) The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents. Adv Drug Deliv Rev 77:3–11CrossRefPubMed
29.
Zurück zum Zitat Scaglione F (2015) Can we transfer pharmacokinetics/pharmacodynamics of antimicrobials into clinical practice? Int J Antimicrob Agents 46(1):S40–S42CrossRefPubMed Scaglione F (2015) Can we transfer pharmacokinetics/pharmacodynamics of antimicrobials into clinical practice? Int J Antimicrob Agents 46(1):S40–S42CrossRefPubMed
30.
Zurück zum Zitat Pea F (2016) Practical concept of pharmacokinetics/pharmacodynamics in the management of skin and soft tissue infections. Curr Opin Infect Dis 29(2):153–159CrossRefPubMed Pea F (2016) Practical concept of pharmacokinetics/pharmacodynamics in the management of skin and soft tissue infections. Curr Opin Infect Dis 29(2):153–159CrossRefPubMed
Metadaten
Titel
Intensive multidisciplinary management in critical care patients affected by severe necrotizing soft tissue infections: a cooperative method to improve the efficacy of treatment
verfasst von
Milo Gatti
Laura Elisa Gasparini
Matteo Laratta
Anna Sigurtà
Anna Rossi
Paolo Brioschi
Osvaldo Chiara
Chiara Vismara
Francesco Scaglione
Sergio Arlati
Publikationsdatum
06.03.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 6/2019
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-019-03521-2

Weitere Artikel der Ausgabe 6/2019

European Journal of Clinical Microbiology & Infectious Diseases 6/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.